NCT05203250 Longitudinal Registry Including Patients Treated With Heavy Particles
| NCT ID | NCT05203250 |
| Status | Recruiting |
| Phase | — |
| Sponsor | CNAO National Center of Oncological Hadrontherapy |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2021-06-04 |
| Primary Completion | 2030-06-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2021-06-04 with a primary completion date of 2030-06-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this registry is to collect retrospective and prospective standardized data of patients treated with particle therapy, either with protons or carbon ions, at the National Center for Oncological Hadrontherapy (CNAO) based in Pavia. By keeping track of the patients treated, it will allow the investigators to periodically analyze and evaluate data collected of daily clinical activity. This will help gathering more information on the results of particle therapy and will provide the basis for in depth evaluation of patients' outcome with respect to the delivered treatment.
Eligibility Criteria
Inclusion Criteria: * Patients treated with heavy particles at Fondazione CNAO, Pavia * Patients who have the ability to understand and be willing to sign a written informed consent document Exclusion Criteria: * Patients or legal guardians who are unable to understand informed consent document
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05203250 clinical trial?
This trial is open to participants of all sexes, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05203250 currently recruiting?
Yes, NCT05203250 is actively recruiting participants. Contact the research team at campo@cnao.it for enrollment information.
Where is the NCT05203250 trial being conducted?
This trial is being conducted at Pavia, Italy.
Who is sponsoring the NCT05203250 clinical trial?
NCT05203250 is sponsored by CNAO National Center of Oncological Hadrontherapy. The trial plans to enroll 3,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.